Alfonso Brito

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
T cell immunotherapy is emerging as a powerful strategy to treat cancer, and may offer new opportunities to improve outcomes for patients with glioblastoma (GBM). Our group has developed a chimeric antigen receptor (CAR) T cell immunotherapy for GBM targeting IL-13 receptor a2 (IL13Ra2), a cell surface receptor over-expressed by the majority of high-grade(More)
Ovarian fragments were exposed to 0.5 M sucrose and 1 M ethylene glycol (freezing solution; FS) with or without selenium or Trolox. Histological and ultrastructural analyses showed that the percentages of normal follicles in control tissue and in tissue after exposure to FS + 50 μM Trolox were similar. Trolox prevented endoplasmic reticulum (ER)-related(More)
  • 1